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Abstract
Background: Methicillin-resistant staphylococci (MRS) are major hu-
man pathogens accounting for most hospital-acquired (HA) and com-
munity acquired (CA) infections worldwide. The recent increase inMRS 
in a medical center in Lebanon elicited the determination of SCCmec 
types, genotypes, and prevalence of Panton-Valentine leucociden (PVL) 
and toxic shock syndrome toxin-1 (TSST-1) among the MRS isolates. 
Methods: Thirty-six MRS isolates collected between October 2010 
and September 2011 at a medical center, Lebanon were typed using 
phenotypic and genotypic methods. Antimicrobial susceptibility was 
determined using the disk diffusion agar method. SCCmec typing was 
performed by multiplex PCR and sequence analysis. The prevalence 
of the genes encoding PVL and TSST-1 virulence factors and their 
transcription levels, were determined respectively by PCR and semi-
quantitative real-time PCR. The genomic relatedness of the isolates 
was assessed by random amplified polymorphic DNA (RAPD) analysis. 
Results: Antimicrobial susceptibility revealed three distinct antibio-
types. The predominant SCCmec type found among the MRS isolates 
was type IVa (51%). Twenty-nine percent harbored SCCmec type III 
and 14% harbored SCCmec type II. One isolate harbored SCCmec 
type IVc, and another harbored SCCmec type I. All methicillin-resistant 
Staphylococcus aureus (MRSA) isolates were negative for the gene 
encoding for PVL, and two were positive for the gene encoding for 
TSST-1. RAPD analysis demonstrated high genomic diversity among 
the MRS isolates. 
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Introduction
Staphylococcus aureus is considered a leading 
cause of serious and sometimes life-threatening in-
fections. S. aureus is frequently found on the skin, 
nasal and other mucous membranes of humans, 
and in various food products. In England in 1961, 
the first methicillin-resistant S. aureus (MRSA) was 
reported, only one year following the introduction 
of methicillin. Since then, MRSA has been recog-
nized as a major cause of health-care associated in-
fections. Recently, MRSA has emerged as an impor-
tant community pathogen, and this was followed 
by the recognition of methicillin-resistant coagulase 
negative staphylococci (MRCNS) as important noso-
comial pathogens [1,2]
A study by Tokajian S, 2014, showed that the 
local epidemiology within the Middle East (western 
Asia) region is fluctuating, owing to the introduc-
tion of new strains with the global exchange of 
several clones [3].Another study performed by She-
habi et al. demonstrated the presence of 1-3 clini-
cally important staphylococcal toxin genes more fre-
quently colonizing Jordanian outtpatient infants[4]. 
Furthermore, another study by Nazeer A et al., 
2012 retrieved 73 studies through PubMed using 
the search terms  “methicillin-resistant S. aureus“ 
(MRSA), and Saudi Arabia. They reported MRSA 
incidence or prevalence in patients and/or percent-
age among S. aureus isolates and evaluated these 
metrics against the closest matching SHEA (Society 
for Healthcare Epidemiology of America) /HICPAC 
(Healthcare Infection Control Practices Advisory 
Committee metrics) [5]
Methicillin resistance occurs in Staphylococcus 
species due to the expression of an altered penicil-
lin-binding protein termed PBP2a or PBP2‘, that is 
encoded by the mecA gene [2] The mecA gene is lo-
cated on a mobile staphylococcal cassette chromo-
some mec (SCCmec) element. This element exists in 
MRSA; as well as, MRCNS isolates. To date, at least 
five SCCmec (I-V) types have been described with 
sizes ranging between 21 to 67 kb. The SCCmec 
types (I-V) have aided in the differentiation between 
hospital-acquired (HA) and community-acquired 
(CA) MRS strains. The larger Sccmec types (I-III) 
have been associated with HA infections; whereas, 
the smaller SCCmec types (IV and V) have been as-
sociated with CA infections[6-9].
SCCmec includes the mec gene complex which 
is comprised of the mecA gene and its regulators 
and the ccr gene complex that encodes site-specific 
recombinases. These recombinases are responsible 
for the mobility of the SCCmec[ 10].
Strains of S. aureus isolated from human sources 
can produce a variety of virulence factors. Panton-
Conclusion: This study demonstrated the SCCmec types and the clon-
ality of the MRS strains, allowing the differentiation between HA and 
CA-MRS strains. CA-MRS have increased in the hospital environment 
and rendered highly resistant to erythromycin and clindamycin.
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Valentine leucociden (PVL) is a pore-forming cyto-
toxin that is associated with severe skin and soft tis-
sue infections and necrotizing pneumonia. PVL with 
SCCmec type IV is considered as a marker for CA-
MRSA infections; however, exceptions exist[11]. An-
other main virulence factor includes the toxic shock 
syndrome toxin-1 (TSST-1), which is a superantigen 
having a size of 29.1 kDa. TSST-1 is encoded by the 
tst gene. TSST-1 causes toxic shock syndrome (TSS), 
a severe and potentially fatal manifestation when it 
enters the bloodstream[12].
Infections due to hospital-acquired methicillin re-
sistant staphylococci (HA-MRS) must be controlled 
otherwise they may become permanently present 
in a hospital environment. These endemic MRS are 
very challenging to overcome. In most cases, they 
increase the number of infections, lengthen the 
duration of hospital stay, and raise the amount of 
health-care costs. Since MRS strains are generally 
resistant to a broader range of antimicrobial agents, 
the chances of treatment become limited and the 
spectrum of antibiotic prescriptions changes. There-
fore, the adequate identification of such resistant 
bacteria is a crucial and necessary obligation for 
the selection of the proper antimicrobial treatment 
as well as for the implementation of appropriate 
infection control measures [13].
In Lebanon and the Middle East there are numer-
ous molecular characterization and epidemiological 
studies on MRSA especially during the last decade, 
highlighting their increased prevalence in the region 
[4,14-19]. However, there is scarce data available 
concerning the antibiotic susceptibility profiles, the 
SCCmec types and the genotypes of MRS strains 
that could be circulating in Lebanon. 
Accordingly, the objective of this study was to 
perform phenotypic and genotypic characterization 
of MRS isolates from clinical specimens at a medical 
center in Lebanon.
Materials and methods
Bacterial isolates, identification and 
confirmation of methicillin-resistance by 
phenotypic methods
Thirty-six non-duplicated methicillin resistant 
staphylococci were isolated from clinical speci-
mens (blood, pus, urine, bone, catheter, soft tissue, 
wound swabs, respiratory samples, and exudates) 
of in and out-patients at a medical center in Leba-
non from October 2010 to September 2011. These 
isolates were identified as staphylococci based on 
their Gram stain, colonial morphology, as well as 
their catalase properties. Rapid agglutination and 
coagulase tests were done to distinguish between 
S. aureus and coagulase negative staphylococci 
(CNS). Methicillin resistance was confirmed using an 
oxacillin disk on Mueller-Hinton agar (Oxoid, Eng-
land) according to Clinical and Laboratory Standards 
Institute (CLSI)guidelines[20]. 
Antimicrobial susceptibility testing  
of staphylococcal isolates
Antimicrobial susceptibility testing was performed 
by disk diffusion agar method on Mueller-Hinton 
agar against a panel of antimicrobial agents disks 
(Oxoid, England) according to CLSI guidelines[20].
DNA extraction
DNA was extracted from the staphylococcal 
isolates using illustra bacteria genomic Prep Mini 
Spin kit (GE Healthcare, UK) in accordance with the 
manufacturer’s protocol for purification of genomic 
DNA from Gram-positive bacteria.
Molecular characterization by multiplex 
PCR amplification and DNA sequencing
Three multiplex PCR assays carried out using the 
PCR Sprint Thermal Cycler (Thermo Fisher Scientific, 
Waltham, MA, USA) were used for characterization 
of the methicillin-resistant staphylococcal isolates. 
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Polymerase Chain Reaction
SCCmec-typing Multiplex-PCR 1for typing 
and sub-typing of the SCCmec element 
with the simultaneous detection of the 
mecA gene
The PCR mixture contained nine pairs of primers, 
specific for typing and sub-typing the SCCmec ele-
ment; as well as, an internal control primer for con-
firming the presence of the mecA gene, were used 
in this multiplex polymerase chain reaction (M-PCR) 
assay. The various types and sub-types detected by 
the M-PCR included: I, II, III, IVa, IVb, IVc, IVd, and 
V. M-PCR was performed in a 25 µl final reaction 
mixture with 5 µl of the prepared DNA template 
having a final concentration 10 μg/ml, 2.5 µl of 10x 
Taq DNA polymerase buffer with KCl (Fermentas, 
USA), 2.5 µl of MgCl2 (25mM) (Fermentas, USA), 
0.2 µl of Taq DNA polymerase (5U/μl) (Fermentas, 
USA), 1 µl of 5 mM dNTPs (Fermentas, USA), 13.4 
µl of nuclease free distilled water (Amresco, USA) 
and 0.2 µl of each primer (Thermo Scientific Inc., 
USA)[13].
Mec gene complexcharacterization  
M-PCR 2
Two pairs of primers were used in this M-PCR 
assay to characterize the mec gene complex as ei-
ther class A or B. The M-PCR was performed as 
described in 2.5.1 with thefollowing modification: 
13.64 µl of nuclease free distilled water (Amresco, 
USA) and 0.08 µl of each primer, (Thermo Scientific 
Inc., USA)[13]. 
Ccr gene complex characterization  
M-PCR 3
Six primers were used in this M-PCR assay to 
characterize the ccr gene complex into four allo-
types (types 1, 2, 3, and 5). The M-PCR was per-
formed as described in 2.5.2
Amplification was performed using the same cy-
cling conditions for all three sets of M-PCR reactions 
with denaturation at 94°C for 5 min; 35cycles of 
94°C for 45 s, 56°C for 45 s, and 72°C for 1.5 min; 
and extension at 72°C for 10 min.
MRSA-PVL PCR.
Was performedto detect the PVL toxin gene. The 
PCR was performed as described in Amplification 
was performed with denaturation at 94°C for 5 
min; 35 cycles of 94°C for 10 s, 52°C for 20 s, and 
72°C for 40 s; and extension at 72°C for 5 min.
Gel electrophoresis
The amplicons from M-PCR1, 2, and 3 were sepa-
rated on 2% agarose gels using a suitable DNA lad-
der; either, a 50 bp DNA ladder (Fermentas, USA) or 
a 123 DNA ladder (Sigma-Aldrich, USA). Gels were 
visualized under a UV transilluminator(Haakebuchler 
Instruments Inc, USA) and captured using Olympus 
digital camera, and the DigiDoc-ItProgram (UVP, UK). 
The amplicons were purified using the QIAquick Gel 
Extraction Kit (Qiagen, Valencia, California) and se-
quenced by the ABI 3100 genetic analyzer (Applied 
Biosystems, Foster City, CA,USA).
RNA extraction& reverse transcription
RNA extraction was performed using the illustra 
RNAspin Mini RNA Isolation kit (GE healthcare, UK) 
for all MRSA isolates (n=13). Subsequently,reverse 
transcription was performed using the QuantiTect® 
Reverse Transcription Kit (QIAGEN, Germany) to 
synthesize cDNA from the extracted RNA. 
Real Time Semi-Quantitative qRT- PCR
qRT- PCRwas carried out using the Bio-Rad CFX96 
Real Time System C1000 Thermal Cycler (Germany) 
to determine the transcription levels of the gene 
encoding TSST-1.The qRT-PCR was performed in a 
20 µl final reaction mixture with 10 µl of QuatiFast 
SYBR Green PCR master mix, 4 µl of RNase free 
H2O, 2 µl of forward primer having a concentration 
of 5μM, 2 µl of reverse primer having a concentra-
tion of 5μM, and 2 µl of synthesized cDNA. The 
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following cycling conditions were used: denatura-
tion at 94°C for 5 min; 40 cycles of 94°C for 10 s, 
56°C for 20 s, and 72°C for 40 s; and extension at 
72°C for 5 min. Data analysis was performed using 
the Bio-Rad CFX Manager software (BioRad, USA).
Random Amplified Polymorphic DNA 
analysis (RAPD)
RAPD analysis was performed in order to detect 
the genomic polymorphisms of the thirty-six MRSA 
isolates. RAPD was done using the Ready-To-Go 
RAPD Analysis Beads kit (GE Healthcare, UK Lim-
ited) as specified by the manufacturer, using the 




Out of thethirty-six non-duplicated methicillin 
resistant staphylococci (MRS) collected from clini-
cal specimens, thirteen were S. aureus and twenty-
three were coagulase negative staphylococci (CNS). 
Of these MRS isolates 27.8% were recovered from 
outpatients. Twenty-five percent came from patient 
suites, 14% from the ICU, 11% from the NICU, 11 
% from the operating theater, 5.6% from the chil-
dren’s wing, and 5.6% from the recovery room. 
Sources of the MRS isolates were pus/tissue (n = 6), 
wound swabs (n = 9), blood (n = 11), respiratory tract 
(n = 4), urine (n = 2), and miscellaneous specimens (n 
= 4). The majority of the MRS isolates were isolated 
from males (56%) and in the age group ≥ 40 years 
(67%) (Tables: 1a and 1b).
Antimicrobial susceptibility
The disk-diffusion agar technique identified all 
36 staphylococcal isolates as methicillin resistant. All 
36 (100%) bacterial isolates were resistant to oxacil-
lin, ampicillin, penicillin, augmentin, and cefalotin. 
However, all (100%) were sensitive to vancomycin 
and teicoplanin. The percentage of methicillin-re-
sistant coagulase-negative staphylococci (MRCNS) 
Table 1a. Clinical data and sources of MRSA isolates








2 Outpatient 20/9/10 Abdomen Wound Swab F/16
3 Patient suites 28/9/10 Venous Blood M/72
4 Outpatient 7/10/10 NA Urine F/56
5 Outpatient 16/10/10 Venous Blood NA
6 Patient suites 20/1/11 Placenta Tissue F/62
7 Patient suites 20/2/11 Respiratory Tract Sputum M/45
10 Patient suites 6/3/11 Throat Swab M/22
20 Outpatient 6/6/11 Arm Wound Swab F/59
23 Operating Theater 21/6/11 NA Bone M/44
26 Patient suites 30/6/11 NA Wound Swab M/46
27 Outpatient 27/7/11 Leg Wound Swab F/28
28 Outpatient 29/7/11 Back Wound Swab M/73
29 Recover Room 8/8/11 NA Wound Swab F/2 days
*MRSA: methicillin resistant S. aureus, NA: not available, M: male, F: female
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which were resistant to clindamycin and erythromy-
cin were 65% and 91% respectively; whereas, the 
percentage of methicillin-resistant S. aureus (MRSA) 
which were resistant to clindamycin and erythromy-
cin were 31% and 38% respectively.
SCCmec typing
The SCCmec typing M-PCR1 assay included spe-
cific primers for the various SCCmec types, as well 
as an internal control primer for the detection of the 
mecA gene. This single M-PCR assay determined 
SCCmec types and subtypes I, II, III, IVa, IVb, IVc, 
IVd, and V with the simultaneous discrimination be-
tween MRS and methicillin sensitive staphylococci 
(MSS) isolates (Figure 1). 
M-PCR1 showed that 35/36 (97.2%) of the MRS 
isolates were positive for the mecA gene confirm-
ing methicillin resistance. Isolate 1 was negative for 
Table 1b. Clinical data and sources of MRCNS isolates








1 Outpatient 10/9/10 NA Urine M/97
8 Children’s Wing 17/2/11 Venous Blood M/3 months
9 Outpatient 28/2/11 Leg Wound Swab M/50
11 ICU 9/3/11 Venous Blood M/82
12 ICU 15/3/11 Venous Blood F/81
13 ICU 22/3/11 Respiratory Tract Sputum M/57
14 Outpatient 22/3/11 Skin Ulcer Blood F/53
15 Patient suites 10/4/11 Venous Pus M/77
16 Patient suites 11/4/11 Venous Blood F/38
17 NICU 13/4/11 Lungs Blood M/1 day
18 NICU 2/6/11 Venous DTA M/0
19 Operating Theater 3/6/11 Left hip Blood F/60
21 Outpatient 9/6/11 Neck Tissue F/55
22 NICU 13/6/11 Left Eye Wound Swab M/2 days
24 Patient suites 23/6/11 NA Exudates M/74
25 Patient suites 27/6/11 NA Tissue M/76
30 NICU 4/9/11 NA Catheter M/1 day
31 Operating Theater 8/9/11 NA Tissue F/42
32 Recovery Room 6/9/11 Left Thigh Wound Swab F/79
33 Operating Theater 8/9/11 NA Catheter F/42
34 ICU 10/9/11 Venous Blood M/80
35 ICU 14/9/11 Venous Blood F/69
36 Children´s Wing 17/9/11 Venous Blood M/1 month
* MRCNS: methicillin resistant coagulase-negative staphylococci, NA: not available, M: male, F: female, ICU: intensive care 
unit, NICU: neonatal intensive care unit, DTA: deep tracheal aspirate
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the mecA gene; however, it was phenotypically re-
garded as a methicillin resistant strain by the disk-
diffusion agar method. 
SCCmec typing also allowed for further typing 
and sub-typing of the MRS isolates, revealing the 
following: eighteen MRS isolates (51%) contained 
SCCmec type IVa (776 bp), ten MRS isolates (29%) 
contained SCCmec type III (280 bp), five MRS isolates 
(14%) contained SCCmec type II (398 bp), one MRS 
isolate (3%) contained SCCmec type IVc (200 bp), 
and one MRS isolate (3%) contained SCCmec type I 
(613 bp). No SCCmec type V isolates was detected.
MRSA-PVL PCR
A total of 13 cultured MRSA isolates were sub-
jected to MRSA-PVL PCR and none were PVL gene 
positive.
Real Time semi-quantitative qRT- PCR 
Assay for detecting the gene encoding for the 
TSST-1 virulence factor showed that 2/13 MRSA iso-
lates (isolates 2 and 3) were positive for the tst gene.
Random amplified polymorphic DNA 
analysis (RAPD)
In order to determine the genetic relatedness of 
these MRS strains, genotyping was done using Ran-
dom Amplified Polymorphic DNA (RAPD) analysis. 
RAPD revealed 8 distinct clusters. These types were 
designated type A, B, C, D, E, F, G, and H; each with 
a prevalence of 8%, 17%, 25%, 14%, 19%, 3%, 
11%, and 3% respectively.
The predominant RAPD type C included 9 me-
thicillin resistant coagulase-negative staphylococci 
(MRCNS) isolates, having 58.5% genomic similar-
ity; five of them were CA and four were HA strains. 
All of these isolates were resistant to erythromycin, 
and all except three were resistant to clindamycin. 
Moreover, all were sensitive to the glycopeptides 
class of antimicrobial agents (vancomycin and te-
icoplanin). Isolates 12, 13 and 15 of RAPD type C 
were genetically identical, all three containing SC-
Cmec type IVa, indicating that they are community 
acquired strains. Isolates 12 and 13 were derived 
from the ICU and isolate 15 from patients’ suites. 
The RAPD type E included 7 MRS isolates (6 
MRSA and 1MRCNS), having 65.1% genomic sim-
ilarity; four were HA and three were CA strains. 
These isolates were all susceptible to the glycopep-
tides. All but three were sensitive to erythromycin, 
and only two strains were resistant to clindamycin.
The RAPD type B included 6 MRCNS isolates, 
having 55% genomic similarity; three were HA and 
three were CA strains. The vast majority of these 
isolates were resistant to clindamycin and erythro-
mycin except for one isolate which was sensitive 
to both. All were susceptible to the glycopeptides. 
Isolates 21 and 22 of RAPD type B were genetically 
identical. Both were hospital acquired strains having 
SCCmec type II. Isolate 21 was isolated from an out-
patient while isolate 22 was isolated from the NICU. 
The RAPD type D included 5 methicillin resistant 
S. aureus (MRSA) isolates, having 55.3% genomic 
similarity; four were CA and one was a HA strain. 
These isolates were all sensitive to clindamycin, 
Figure 1. Gel electrophoresis of the M-PCR assay for the 
characterization of the SCCmectypes in MRS isolates. Lane 1 
of the upper and lower gels represents the molecular weight 
marker (L: 50 bp ladder); lane 2 of the upper and lower gels 
represents the negative control (NC)
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erythromycin, and the glycopeptides. Isolates 2 and 
3 of RAPD type D were genetically identical contain-
ing SCCmec type IVa; and hence, were CA strains. 
Isolate 2 was isolated from an out-patient whereas 
isolate 3 was isolated from patients’ suites. These 
2 MRSA isolates were positive for the TSST-1 toxin 
gene.
The RAPD type G included 4 MRS isolates (2 
MRSA and 2 MRCNS), having 30.2% genomic simi-
larity; three were HA and one was a CA strain. 
These isolates were all susceptible to the glycopep-
tides; however, they were resistant to erythromycin. 
All but one isolate were resistant to clindamycin.
The RAPD type A included 3 MRCNS isolates, 
having 45.6% genomic similarity; two were CA and 
1 was a HA strain. All three isolates were resistant 
to erythromycin and sensitive to glycopeptides, and 
one was sensitive to clindamycin.
The RAPD type H included only 1 MRCNS isolate. 
This isolate was HA, for it contained SCCmec type 
III. It was resistant to clindamycin and erythromycin 
and sensitive to the glycopeptides.
The RAPD type F also included only 1 MRCNS 
isolate which did not demonstrate the presence of 
the mecA gene; it was only phenotypically regarded 
as a methicillin resistant strain. This isolate was sen-
sitive to clindamycin, erythromycin, and glycopep-
tides (Figures 2 & 3). 
Discussion
This study highlighted the antimicrobial-resistance 
profiles of the collected MRS isolates, which can 
serve as a useful reference for assessing the antibi-
otic resistant trends of the MRS strains in Lebanon.
Antimicrobial susceptibility testing showed that 
MRCNS are inclined to be more multi-drug resistant 
Figure 2. RAPD gel analysis for the MRS isolates; NC: negative 
control; L: molecular weight marker (100 bp ladder).
Figure 3. Dendrogram obtained from RAPD analysis, 
depicting clonal relationship (eight clusters: A, B, C, D, E, 
F, G, & H) of the 36 MRS clinical isolates obtained from a 
Medical Center, Lebanon.
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SCC mec type RAPD type
1 CNS 1 N/A F
2 S.aureus 1 IVa D
3 S.aureus 1 IVa D
4 S.aureus 2 III G
5 S.aureus 1 IVa D
6 S.aureus 1 IVc E
7 S.aureus 2 III G
8 CNS 2 II C
9 CNS 2 III H
10 S.aureus 1 IVa D
11 CNS 3 IVa A
12 CNS 2 IVa C
13 CNS 2 IVa C
14 CNS 2 II C
15 CNS 2 IVa C
16 CNS 2 IVa A
17 CNS 3 II C
18 CNS 2 IVa B
19 CNS 1 IVa B
20 S.aureus 1 III D
21 CNS 2 II B
22 CNS 2 II B
23 S.aureus 2 III E
24 CNS 2 I C
25 CNS 2 IVa B
26 S.aureus 3 III E
27 S.aureus 1 IVa E
28 S.aureus 1 IVa E
29 S.aureus 1 IVa E
30 CNS 2 III E
31 CNS 3 IVa C
32 CNS 2 III B
33 CNS 3 IVa C
34 CNS 2 III A
35 CNS 2 III G
36 CNS 3 IVa G
*CNS: coagulase-negative staphylococci, N/A: non-available
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than MRSA. Similar results have been documented 
in several studies [21]. The percentage of resistance 
to erythromycin and clindamycin in MRCNS isolates 
in this study was 91% and 65% respectively; where-
as, the percentage of resistance to erythromycin 
and clindamycin in MRSA isolates was 38% and 
31% respectively. The high resistance rates to eryth-
romycin and clindamycin renders the use of these 
antimicrobial agents inefficient in the treatment of 
MRS infections. Currently, the glycopeptides (van-
comycin and teicoplanin) are considered the drugs 
of last resort against MRS infections; however, the 
emergence of vancomycin-intermediate and resist-
ant staphylococcal strains has imposed a serious 
threat [22]. Moreover, all of the Staphylococcus iso-
lates in this study were sensitive to vancomycin and 
teicoplanin.
Molecular characterization of the studied MRSA 
isolates by performing staphylococcal cassette 
chromosome mec (SCCmec) typing using M-PCR 
revealed that 53.8% of these MRSA isolates were 
SCCmec type IVa, 38.5% were SCCmec type III and 
7.7% were SCCmec type IVc. 
None of the MRSA isolates were pvl positive, but 
15.4% of MRSA isolates were tst positive by qRT-
PCR. The presence of the tst gene, encoding for 
TSST-1, in isolates 2 and 3 is alarming because it can 
contribute to the invasiveness and severity of the S. 
aureus infection. Therefore, routine investigation for 
genes encoding virulence factors is recommended 
in order to predict potential diseases that may be 
associated with these virulence factors. This may 
lead to the application of the appropriate measures 
if possible to manage such diseases.
Furthermore, SCCmec typing by M-PCR allowed 
for the differentiation between HA-MRSA and CA-
MRSA[23]. Established molecular criteria classified 
isolates of MRSA harboring SCCmec type I-III as 
HA-MRSA and those harboring SCCmec type IV-V 
as CA-MRSA. The majority (61.5%) of the collect-
ed MRSA isolates were CA. The existence of these 
isolates carrying SCCmec type IV in the hospital 
indicates the presence of a community reservoir 
or possibly the entrance of these isolates into the 
hospital environment; hence, CA-MRSA isolates are 
no longer confined to the community [24-26]. This 
change in the epidemiology of CA-MRSA has raised 
speculations concerning the origin of CA and HA 
MRSA. The basic structure of the SCCmec genetic 
element can provide an insight about the origin of 
CA and HA-MRSA. As noted earlier, the various 
SCCmec types share some basic structural features, 
including direct repeats, the ccr gene complex and 
the mec gene complex. The structural differences 
between the community-associated SCCmec types 
IV-V and the hospital-associated SCCmec types I-III 
rely mainly on the larger size and the presence of 
additional resistance determinants associated with 
HA-MRSA strains. Therefore, a possible explanation 
is that CA-MRSA has entered the hospital setting, 
acquired additional fragments and resistance deter-
minants rendering them HA.
CA-MRSA isolates have been known to be sus-
ceptible to non-beta-lactam antimicrobial agents. 
The antimicrobial susceptibility results obtained 
in this study confirm it; while 80% of HA-MRSA 
isolates showed multidrug-resistant phenotypes, 
all CA-MRSA isolates presented with a multi-drug 
susceptible pattern. Even though the CA-MRSA iso-
lates were susceptible to multiple classes of antimi-
crobial agents as compared to HA-MRSA, 54% of 
the patients were hospitalized, indicating the sever-
ity of infections caused by CA-MRSA.
SCCmec typing and RAPD analysis revealed that 
the staphylococcal isolates 2 and 3 which were 
characterized as CA-MRSA belonging to cluster D, 
isolates 12, 13 and 15 which were characterized 
as MRCNS carrying SCCmec type IVa belonging 
to cluster C, and isolates 21 and 22 which were 
characterized as MRCNS carrying SCCmec type II 
belonging to cluster B, were genomically identical, 
and they were isolated within the same time period, 
hence, indicating possible outbreak strains[27]. 
The SCCmec genetic elements were highly preva-
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lent among MRCNS in this study. Moreover, there 
were strains of MRCNS and MRSA that showed close 
or possible genomic relatedness by RAPD (isolates 
29 & 30 and isolates 7 & 35 showed 85.7% and 
50% genomic similarity respectively). This indicates 
that MRCNS constitute potential reservoirs of the 
SCCmec that provide S. aureus with antimicrobial-
resistant determinants [28-32].
RAPD analysis revealed the presence of multiple 
SCCmec types within a single RAPD cluster. This 
indicates that staphylococcal clones having similar 
genomes may have developed methicillin-resistance 
upon the acquisition of the SCCmec genetic ele-
ment by methicillin-sensitive strains of staphylococci. 
The MRS isolates were diversified as defined by 
RAPD analysis, and there was a significant genomic 
heterogeneity particularly among staphylococcal iso-
lates carrying the SCCmec type IV, which clustered 
into six RAPD types. This observation points out 
to the enhanced ability of SCCmec type IV genetic 
element to become mobilized, which is followed 
by its insertion into the chromosome of Staphylo-
coccus species. Further, SCCmec types I, II and III 
were more commonly associated with HA isolates, 
whereas types IVa and IVc were more commonly 
associated with CA isolates.The small size associ-
ated with SCCmec type IV might aid in the trans-
fer of this element on a plasmid or bacteriophage 
and hence, contributing to the enhanced spread of 
methicillin-resistance [33].
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